The minimal disease severity at which patients with the sleep apnea/hypopnea syndrome
(SAHS) gain benefit from treatment is not well characterized, although a pilot study of …

The aim of this trial was to evaluate the effectiveness of continuous positive airway pressure
(CPAP) in patients with mild sleep apnea–hypopnea syndrome (SAHS). One hundred forty …

Application of continuous positive airway pressure (CPAP) as the standard treatment for
sleep apnea/hypopnea syndrome (SAHS) is a moot point. Studies on the effectiveness of …

Continuous positive airway pressure (CPAP) is worldwide considered as the standard
treatment of sleep apnea/hypopnea syndrome (SAHS) although studies on the effectiveness …

There is randomized controlled evidence that patients with sleep apnea–hypopnea
syndrome (SAHS) treated with continuous positive airway pressure (CPAP) have improved …

Continuous positive airway pressure (CPAP) therapy improves daytime function in the sleep
apnea/hypopnea syndrome (SAHS) but it is unclear which patients benefit and what factors …

Patients with the sleep apnea/hypopnea syndrome (SAHS) treated by nasal continuous
positive airway pressure (CPAP) need to use CPAP long-term to prevent recurrence of …

Continuous positive airway pressure (CPAP) therapy is widely prescribed for patients with
the sleep apnea/hypopnea syndrome (SAHS), but the use of CPAP for such patients is …

A common clinical dilemma faced by sleep physicians is in deciding the level of severity at
which patients with obstructive sleep apnea (OSA) should be treated. There is particular …

BACKGROUND: Continuous positive airway pressure (CPAP) is an effective treatment in
patients with moderate and severe sleep apnoea/hypopnoea syndrome (SAHS), but the …